ReviewJournal of gastrointestinal cancer2026
The Role of MRI in Non-Operative Management of Locally Advanced Rectal Cancer.
Review in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in total neoadjuvant therapy have significantly increased complete response rates, and non-operative management of locally advanced rectal cancer has emerged as a viable alternative to traditional surgical resection for select patients achieving a complete clinical response after neoadjuvant therapy. There has been growing evidence in support of non-operative management, demonstrating promising survival outcomes and organ-preservation benefits. Appropriate patient selection at restaging and early detection of local tumor recurrence are key to positive oncological outcomes. High-resolution MRI, particularly when combined with diffusion-weighted imaging, can offer unmatched evaluation of treatment response, detection of residual disease, and identification of local recurrence. Standardized imaging protocols and emerging tools such as radiomics are further enhancing the precision of tumor assessment. This article provides a comprehensive synthesis of current evidence and reviews the critical role of MRI for the successful implementation of non-operative in clinical practice.
Indexed as
Identifiers
41896438What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.